Author: McKinley Corbley / Source: Good News Network
A new HIV vaccine is inspiring “cautious” hope in scientists after it passed human trials with “promising” results.
The randomized, double-blind, placebo-controlled study showed that the vaccine evoked an anti-HIV immune system response in all 393 of the patients who received the treatment.
The research team developed the treatment as a “mosaic” vaccine, meaning that it was created using immunity properties against multiple strains of HIV in order to maximize protection. The mosaic vaccine was then delivered to healthy patients between the ages of 18 and 50 who did not already have the disease. The participants were given a series of four vaccines across 48 weeks at HIV clinics in US, Rwanda, Uganda,…
The post HIV Vaccine Inspires Hope After ‘Promising’ Results in Human Trials appeared first on FeedBox.